Gene therapy preparations manufacturing · Massachusetts

CRISPR Therapeutics 33 New York Ave

Name: CRISPR Therapeutics 33 New York Ave Workplace Safety Data
Creator: PlainSafetyScore
License: https://creativecommons.org/publicdomain/zero/1.0/

Framingham, MA · ~79 workers · 2 years of OSHA Injury Tracking Application data.

Compiled by PlainSafetyScore · August 25, 2026

A
Excellent Safety Record: 0.8
Avg TCR: 3.3
Industry avg: 0
Fatalities

Subscribe to safety-record updates (RSS)

The verdict

CRISPR Therapeutics 33 New York Ave runs at 26% of its industry's injury rate - far safer than the typical Gene therapy preparations manufacturing workplace, earning a grade A.

CRISPR Therapeutics 33 New York Ave: 0.8 TCR = 26% of Gene therapy preparations manufacturing BLS 3.3 · 2y Form 300A (see methodology below)

CRISPR Therapeutics 33 New York Ave safety composite

CRISPR Therapeutics 33 New York Ave scores strongest on total case rate (tcr) (safer than 67% of same-industry peers) and weakest on dart rate (safer than 19%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

46/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR): C 0.85 per 100 workers

Safer than 67% of industry peers
DART rate: F 1.7 per 100 workers

Safer than 19% of industry peers
Fatalities: D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

CRISPR Therapeutics 33 New York Ave: 0.0 → 1.7 TCR

Peak year 2024 @ 1.7 TCR · DART/TCR 2× in 2024

CRISPR Therapeutics 33 New York Ave's TCR rose 1.7 from 0.0 in 2023 to 1.7 in 2024. In 2024, DART was 2× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 325414 · Framingham, MA AT/BELOW-IND · SMALL

Grade A · TCR 0.8 · 26% of ind

DART 1.7 DART
RANK #23/37
PHOTO Jackson ImmunoResearch
BOOK 2y book
INJ 1 inj
SIZE ~79 FTE

Nearest TCR peer: Jackson ImmunoResearch (0.0 TCR gap)

Read with this employer → · Industry book → · Massachusetts employers → · Look up another →

Jackson Immuno

0.9
Iovance Cell T

0.9
This site

0.8
Miltenyi Biote

0.8
Celularity

0.8

What this shows CRISPR Therapeutics 33 New York Ave averages 0.8 TCR (26% of the Gene therapy preparations manufacturing BLS benchmark).

CRISPR Therapeutics 33 New York Ave TCR series: 2023=0 · 2024=1.7 · BLS 3.3

Where CRISPR Therapeutics 33 New York Ave falls in its industry

234 Gene therapy preparations manu establishments

Safer than 67% of graded establishments in this industry, whose median TCR is 1.2.

Grade A

More dangerous than peersSafer than peers

Narrower to Massachusetts alone (the establishments it most directly competes with for workers and contracts): ranked #23 safest of 37 Gene therapy preparations manu employers in Massachusetts.

CRISPR Therapeutics 33 New York Ave (79 employees, TCR 0.8) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

CRISPR Therapeutics 33 New York Ave has fewer employees than the Gene therapy preparations manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year	TCR	DART	Injuries	Illnesses	Fatalities
2024	1.7	1.7	1	0	0
2023	0.0	0.0	0	0	0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · MA · Framingham

234 Gene therapy preparations manufacturing employers nationwide with a credible TCR · 10,108 rated employers in Massachusetts with headcount on file · 115 employers in Framingham, MA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel	Establishment	Place	Metric
NAICS-TCR	Jackson ImmunoResearch	WEST GROVE, PA	0.9 TCR
NAICS-TCR	Iovance Cell Therapy Center (iCTC)	PHILADELPHIA, PA	0.9 TCR
NAICS-TCR	Miltenyi Biotec - San Jose	SAN JOSE, CA	0.8 TCR
NAICS-TCR	Celularity	FLORHAM PARK, NJ	0.8 TCR
STATE-SIZE	Medical Area Total Energy Plant, LLC.	BOSTON	79 FTE
STATE-SIZE	NE DISTRIB CENTER (SUTTON)-MA25	WHITINSVILLE	79 FTE
STATE-SIZE	AMESBURY-MA02	AMESBURY	79 FTE
STATE-SIZE	1800	CHELMSFORD	79 FTE
CITY-NEAR	TJXCORP	Framingham	2,847 FTE
CITY-NEAR	TJX Corporate	Framingham	2,122 FTE
CITY-NEAR	NBC Operating, LP	Framingham	1,483 FTE
CITY-NEAR	4701-912VSB	Framingham	1,215 FTE
NAT-TCR	Closure Systems International Americas, Inc.	Salt Lake City, UT	0.8 TCR
NAT-TCR	Mouldagraph Corporation	Nitro, WV	0.8 TCR
NAT-TCR	Walnut Ridge Service Center	Urbandale, IA	0.8 TCR
NAT-TCR	Tailor Welded Blanks Monroe	Monroe, MI	0.8 TCR
NAT-SIZE	St. Augustine Plantation	Tallahassee, FL	79 FTE
NAT-SIZE	Garden Valley Retirement Village	Garden City, KS	79 FTE
NAT-SIZE	Valley Nashville	Nashville, TN	79 FTE
NAT-SIZE	Portus Stevedoring LLC	Jacksonville, FL	79 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.